脑膜瘤患者术后癫痫发作:优化抗癫痫药物治疗的患者选择
该回顾性研究分析了2010至2015年间在本机构接受治疗的283例组织学确诊的颅内脑膜瘤患者,旨在确定围手术期癫痫发作的易感因素及抗癫痫药物的影响。术后癫痫发作的危险因素包括凸面位置(OR 2.05)、额顶位置(OR 4.42)和术前癫痫发作(OR 2.65);在无癫痫发作患者中,上述两个位置及术前影像中线移位(OR 4.15)与术后癫痫发作显著相关。对有这些危险因素的患者进行抗癫痫治疗,可使术后第1年内任何时间点癫痫发作的可能性降低约40%,但未达统计学显著。
要点
- 术后癫痫发作的危险因素为凸面位置、额顶位置和术前癫痫发作。
- 无癫痫发作患者中,凸面/额顶位置及中线移位与术后癫痫发作显著相关。
- 对有危险因素者抗癫痫治疗可使术后1年内癫痫发作风险降低约40%,但未达统计学显著。
核心结论
- 对具有至少1个危险因素的无癫痫发作脑膜瘤患者,预防性抗癫痫治疗可能是有理由的。
- 需要高质量随机对照试验来验证这些因素并明确抗癫痫药物在脑膜瘤实践中的作用。
研究设计与样本
- 回顾性研究,纳入作者所在机构2010年至2015年间接受治疗的组织学确诊的颅内脑膜瘤患者,最终283例符合选择标准。
- 评估临床和影像数据,采用二元逻辑回归进行多因素分析,采用生存分析评估抗癫痫治疗的效果。
主要发现
- 283例患者中,术前有癫痫发作68例(24%),术后有癫痫发作48例(17%)。
- 68例术前癫痫发作患者中,19例继续有发作;29例无癫痫发作患者术后出现新发癫痫发作。
- 术后癫痫发作的危险因素为凸面位置(OR 2.05 [95% CI 1.07-3.98],p = 0.030)、额顶位置(OR 4.42 [95% CI 1.49-13.16],p = 0.007)和术前癫痫发作(OR 2.65 [95% CI 1.37-5.24],p = 0.005)。
- 在无癫痫发作患者中,上述两个位置以及术前影像存在中线移位(OR 4.15 [95% CI 1.54-11.24],p = 0.005)与术后癫痫发作显著相关。
- 对有这些危险因素的患者进行抗癫痫治疗,可使术后第1年内任何时间点癫痫发作的可能性降低约40%,但未达统计学显著。
临床怎么用
- 作者认为,对具有至少1个危险因素的无癫痫发作脑膜瘤患者,预防性抗癫痫治疗可能是有理由的。
- 作者指出,需要高质量随机对照试验来验证这些因素并明确抗癫痫药物在脑膜瘤实践中的作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epilepsy is a major cause of morbidity and mortality in meningioma patients. The aims of this study were to determine which factors predispose meningioma patients to developing perioperative seizures and to understand the impact of antiepileptic drugs. METHODS: Patients treated for a histologically-confirmed intracranial meningioma at the authors' institution between 2010 and 2015 were retrospectively examined. Clinical and imaging data were assessed. Multivariate analysis was performed using binary logistic regression. The effect of antiepileptic treatment was assessed using survival analysis. RESULTS: Two hundred and eighty-three patients met the selection criteria; seizures were present in 68 preoperatively (24%) and in 48 patients (17%) following surgery. Of the 68 with preoperative seizures, 19 continued to have them, whereas de-novo seizures arose postoperatively in 29 seizure-naïve patients. Risk factors of postoperative seizures were convexity location (OR 2.05 [95% CI 1.07-3.98], p = 0.030), fronto-parietal location (OR 4.42 [95% CI 1.49-13.16], p = 0.007) and preoperative seizures (OR 2.65 [95% CI 1.37-5.24], p = 0.005). The two locations, in addition to the presence of midline shift on preoperative imaging (OR 4.15 [95% CI 1.54-11.24], p = 0.005), were significantly correlated with postoperative seizures in seizure-naïve patients. Antiepileptic treatment in patients with those risk factors reduced the possibility of seizures at any time point within the 1st year postoperatively by approximately 40%, although this did not meet statistical significance. CONCLUSION: Prophylactic antiepileptic treatment might be warranted in seizure-naïve meningioma patients with ≥ 1 risk factor. High-quality randomised controlled trials are required to verify those factors and to define the role of antiepileptics in meningioma practice.
引用
- Islim AI, Ali A, Bagchi A, et al. Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy. J Neurooncol. 2018. PMID: 29959695. doi:10.1007/s11060-018-2941-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。